Wockhardt Limited

NSEI:WOCKPHARMA 株式レポート

時価総額：₹148.6b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Wockhardt マネジメント

マネジメント 基準チェック /44

Wockhardt'sの CEO はMurtaza Khorakiwalaで、 Apr2009年に任命され、 の在任期間は 15.17年です。 の年間総報酬は₹ 21.20Mで、 95.3%給与と4.7%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.19%を直接所有しており、その価値は₹ 174.26M 。経営陣と取締役会の平均在任期間はそれぞれ12.8年と7.6年です。

主要情報

Murtaza Khorakiwala

最高経営責任者

₹21.2m

報酬総額

CEO給与比率95.3%
CEO在任期間15.5yrs
CEOの所有権0.2%
経営陣の平均在職期間13.1yrs
取締役会の平均在任期間7.9yrs

経営陣の近況

Shareholders Will Probably Not Have Any Issues With Wockhardt Limited's (NSE:WOCKPHARMA) CEO Compensation

Jun 22
Shareholders Will Probably Not Have Any Issues With Wockhardt Limited's (NSE:WOCKPHARMA) CEO Compensation

Recent updates

What Wockhardt Limited's (NSE:WOCKPHARMA) 27% Share Price Gain Is Not Telling You

Aug 20
What Wockhardt Limited's (NSE:WOCKPHARMA) 27% Share Price Gain Is Not Telling You

Wockhardt (NSE:WOCKPHARMA) Is Making Moderate Use Of Debt

Jul 27
Wockhardt (NSE:WOCKPHARMA) Is Making Moderate Use Of Debt

Wockhardt Limited (NSE:WOCKPHARMA) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Jun 30
Wockhardt Limited (NSE:WOCKPHARMA) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Shareholders Will Probably Not Have Any Issues With Wockhardt Limited's (NSE:WOCKPHARMA) CEO Compensation

Jun 22
Shareholders Will Probably Not Have Any Issues With Wockhardt Limited's (NSE:WOCKPHARMA) CEO Compensation

Subdued Growth No Barrier To Wockhardt Limited (NSE:WOCKPHARMA) With Shares Advancing 29%

Feb 21
Subdued Growth No Barrier To Wockhardt Limited (NSE:WOCKPHARMA) With Shares Advancing 29%

There's Reason For Concern Over Wockhardt Limited's (NSE:WOCKPHARMA) Massive 28% Price Jump

Dec 19
There's Reason For Concern Over Wockhardt Limited's (NSE:WOCKPHARMA) Massive 28% Price Jump

There's No Escaping Wockhardt Limited's (NSE:WOCKPHARMA) Muted Revenues

Oct 14
There's No Escaping Wockhardt Limited's (NSE:WOCKPHARMA) Muted Revenues

Is Wockhardt (NSE:WOCKPHARMA) Using Too Much Debt?

Jun 23
Is Wockhardt (NSE:WOCKPHARMA) Using Too Much Debt?

Estimating The Intrinsic Value Of Wockhardt Limited (NSE:WOCKPHARMA)

Feb 18
Estimating The Intrinsic Value Of Wockhardt Limited (NSE:WOCKPHARMA)

Wockhardt (NSE:WOCKPHARMA) Is Making Moderate Use Of Debt

Jan 04
Wockhardt (NSE:WOCKPHARMA) Is Making Moderate Use Of Debt

Shareholders Will Probably Hold Off On Increasing Wockhardt Limited's (NSE:WOCKPHARMA) CEO Compensation For The Time Being

Jul 26
Shareholders Will Probably Hold Off On Increasing Wockhardt Limited's (NSE:WOCKPHARMA) CEO Compensation For The Time Being

Calculating The Intrinsic Value Of Wockhardt Limited (NSE:WOCKPHARMA)

May 18
Calculating The Intrinsic Value Of Wockhardt Limited (NSE:WOCKPHARMA)

Calculating The Fair Value Of Wockhardt Limited (NSE:WOCKPHARMA)

Jan 26
Calculating The Fair Value Of Wockhardt Limited (NSE:WOCKPHARMA)

What Did Wockhardt's (NSE:WOCKPHARMA) CEO Take Home Last Year?

Dec 01
What Did Wockhardt's (NSE:WOCKPHARMA) CEO Take Home Last Year?

CEO報酬分析

Wockhardt の収益と比較して、Murtaza Khorakiwala の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024n/an/a

-₹3b

Mar 31 2024₹21m₹20m

-₹5b

Dec 31 2023n/an/a

-₹5b

Sep 30 2023n/an/a

-₹5b

Jun 30 2023n/an/a

-₹6b

Mar 31 2023₹24m₹23m

-₹6b

Dec 31 2022n/an/a

-₹6b

Sep 30 2022n/an/a

-₹5b

Jun 30 2022n/an/a

-₹3b

Mar 31 2022₹24m₹17m

-₹2b

Dec 31 2021n/an/a

-₹787m

Sep 30 2021n/an/a

-₹567m

Jun 30 2021n/an/a

-₹867m

Mar 31 2021₹24m₹24m

-₹3b

Dec 31 2020n/an/a

-₹2b

Sep 30 2020n/an/a

-₹3b

Jun 30 2020n/an/a

-₹3b

Mar 31 2020₹24m₹24m

-₹2b

Dec 31 2019n/an/a

-₹1b

Sep 30 2019n/an/a

-₹2b

Jun 30 2019n/an/a

-₹2b

Mar 31 2019₹24m₹24m

-₹3b

Dec 31 2018n/an/a

-₹3b

Sep 30 2018n/an/a

-₹3b

Jun 30 2018n/an/a

-₹3b

Mar 31 2018₹24m₹19m

-₹6b

報酬と市場: Murtazaの 総報酬 ($USD 253.64K ) は、 Indian市場 ($USD 368.82K ) の同様の規模の企業の平均を下回っています。

報酬と収益: Murtazaの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Murtaza Khorakiwala (51 yo)

15.5yrs

在職期間

₹21,200,000

報酬

Dr. Murtaza Habil Khorakiwala serves as the Managing Director of Wockhardt Ltd. since April 2009 and has been its Executive Director since March 31, 2009. Dr. Khorakiwala serves as a Director of Khorakiwal...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Habil Khorakiwala
Founder & Executive Chairman20.7yrs₹36.50m0.39%
₹ 578.6m
Murtaza Khorakiwala
MD & Executive Director15.5yrs₹21.20m0.19%
₹ 284.9m
Huzaifa Khorakiwala
Executive Directorno data₹21.20m0.18%
₹ 272.0m
Deepak Madnani
Chief Financial Officer2.3yrsデータなしデータなし
Mahesh Patel
Chief Scientific Officer of New Drug Discoveryno data₹1.71mデータなし
Debolina Partap
Senior Vice President of Legalno dataデータなしデータなし
Neeraj Agarwal
Chief Human Resource Officerno dataデータなしデータなし
Anil Kamath
Senior Vice President of Business Developmentno data₹1.61mデータなし
Zoher Sihorwala
Head of Global Regulatory Affairs10.8yrsデータなしデータなし
Prakash Gupta
President of Supply Chainno dataデータなしデータなし
Ravindra Limaye
Managing Director of Wockhardt UKno dataデータなしデータなし
Lalit Aggarwal
President of Manufacturingno dataデータなしデータなし

13.1yrs

平均在職期間

57yo

平均年齢

経験豊富な経営陣: WOCKPHARMAの経営陣は経験豊富で経験豊富です（平均在職期間は12.8年）。

取締役

名称ポジション在職期間報酬所有権
Habil Khorakiwala
Founder & Executive Chairman20.7yrs₹36.50m0.39%
₹ 578.6m
Murtaza Khorakiwala
MD & Executive Director15.6yrs₹21.20m0.19%
₹ 284.9m
Huzaifa Khorakiwala
Executive Director15.5yrs₹21.20m0.18%
₹ 272.0m
Akhilesh Krishna Gupta
Non-Executive Independent Director4.2yrs₹1.10mデータなし
Vinesh Jairath
Non-Executive & Independent Director7.9yrs₹1.70mデータなし
Zahabiya Khorakiwala
Non-Executive Non- Independent Director7yrs₹300.00kデータなし
Tasneem Vikram Mehta
Non-Executive & Independent Director10.1yrs₹1.60mデータなし
Ahmad Javed
Non Executive Independent Directorless than a yearデータなしデータなし
Amelia Fernandes
Independent Director1.3yrs₹1.00m0.000070%
₹ 104.0k

7.9yrs

平均在職期間

66yo

平均年齢

経験豊富なボード: WOCKPHARMAの 取締役会 は 経験豊富 であると考えられます ( 7.6年の平均在任期間)。